Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-08-21
2007-08-21
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C424S435000, C424S462000
Reexamination Certificate
active
10297004
ABSTRACT:
The invention relates to preparations that are useful in maintaining mammalian blood glucose concentrations. These preparations contain insulin, and a polymeric matrix. The polymeric matrix has a core of biodegradable, hydrophobic polymer, and an outer shell of a biodegradable, hydrophobic polymer. Alternately, the formulations contain insulin, a polymeric matrix, and a histone.
REFERENCES:
patent: 4529589 (1985-07-01), Davydov et al.
patent: 4666704 (1987-05-01), Shalati et al.
patent: 4913908 (1990-04-01), Couvreur et al.
patent: 5310558 (1994-05-01), Pozzi et al.
patent: 6201065 (2001-03-01), Pathak et al.
patent: 6277410 (2001-08-01), Kabanov et al.
Peracchia et al., “Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting.” J. Cont. Rel., 1999, 60, 121-8.
Bobkov Iouri Gennadievich
Davydov Anatoly Borisovich
Kalinin Iouri Tikhosovich
Khromov Gennadiy Ljvovich
Leoniv Boris Ivanovich
Bradley Christina Marchetti
Frohwitter Frohwitter
Laccotripe Zacharakis Maria
Tsang Cecilia J.
LandOfFree
Means for maintenance and/or correction of glucose... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Means for maintenance and/or correction of glucose..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Means for maintenance and/or correction of glucose... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3864057